Last reviewed · How we verify
Obesity
Approved treatments
- Dextrofenfluramine
- Fenmetrazina · Boehringer Ingelheim
- Tenuate · ANI Pharmaceuticals
- Belviq · Eisai
- Amphetamine Sulfate · UCB
- Desoxyn · Ajenat Pharms
Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. - Amphetamine Sulfate · Azurity
- Naltrexon · Institute of Liver and Biliary Sciences, India
- Imcivree · Rhythm
Imcivree works by activating the melanocortin 4 receptor, a protein that helps regulate appetite and metabolism. - Oblean
- Desobesi
- Wellbutrin · GSK (GlaxoSmithKline)
Norepinephrine-dopamine reuptake inhibitor (NDRI) that treats depression and aids smoking cessation without serotonergic side effects. - Fintepla · UCB
Fintepla works by binding to the Alpha-1B adrenergic receptor, which helps regulate the activity of certain neurons in the brain. - Didrex · Pfizer
- Racemic Sibutramine
- Rondimen
- Ozempic · Novo Nordisk
Semaglutide, a GLP-1 analogue, lowers blood glucose by stimulating insulin and inhibiting glucagon secretion in a glucose-dependent manner, and delays gastric emptying. - Sanorex
- Teramine
- Belviq · Columbia University
- Rybelsus · Pfizer
- Wellbutrin · Mclean Hospital
- Xenical · Khoo Teck Puat Hospital
- Elontril · Boehringer Ingelheim
Pipeline
- PF-07081532 · Pfizer Inc. — discontinued
- PF-07976016 · Pfizer Inc. — discontinued
- DEXTROAMPHETAMINE — Phase 3